Table 1.
Compound | Target/Action | Commercial Source | Dose (Ref No) |
---|---|---|---|
compound C (CC) | AMPK inhibition | P5499; Sigma Aldrich (St Louis, MO, USA) | 10 μg [4,18] |
etomoxir (ETOM) | CPT1 inhibition | E1905; Sigma Aldrich (St Louis, MO, USA) | 10 μg [13,18] |
rapamycin (RAPA) | mTOR inhibition | 553210; Calbiochem (San Diego, CA, USA) | 50 μg [15,20] |